Imexpharm

Imexpharm Interest Coverage

The Interest Coverage Ratio of Imexpharm (IMP.VN) as of Oct 26, 2026 is 26.53. In the previous year, Interest Coverage Ratio was 47.79 — a change of -44.50% (lower).

Interest Coverage

26.53

YoY

-44.50%

Last updated:

Interest Coverage Ratio of Imexpharm is 2025 26.53 . Interest Coverage Ratio of Imexpharm was 2024 47.79 . It decreases by -44.50% lower compared to the previous year.

The Imexpharm Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
12.96 VND
Jan 1, 2019
39.06 VND
Jan 1, 2020
85.81 VND
Jan 1, 2021
17.43 VND
Jan 1, 2022
20.66 VND
Jan 1, 2023
23.17 VND
Jan 1, 2024
47.79 VND
Jan 1, 2025
26.53 VND
The Imexpharm Interest Coverage history
YEARInterest CoverageYoY
26.53-44.50%
47.79+106.30%
23.17+12.14%
20.66+18.56%
17.43-79.69%
85.81+119.72%
39.06+201.27%
12.96+67.30%
7.75-51.86%
16.10+105.76%
7.82-27.08%
10.73—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Interest Coverage Ratio of Imexpharm is 26.53 in 2025.

Interest Coverage Ratio of Imexpharm changed from 47.79 to 26.53, representing a -44.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Imexpharm since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Imexpharm with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Imexpharm

All Key Metrics — Imexpharm